Malignant Neoplasm of Female Breast Not Yet Recruiting Phase 2 Trials for Pyrotinib (DB14993)

Also known as: Breast Cancer Females / Breast Cancer, Female / Breast Cancer Female / Breast Cancer - Female / Breast Cancer Female NOS / Female Breast Cancer / Breast neoplasm malignant female / Malignant neoplasm of female breast NOS (disorder) / Malignant neoplasm of female breast (disorder) / Malignant neoplasm of breast (female), unspecified / Malignant neoplasm of female breast, unspecified / Primary malignant neoplasm of female breast (disorder)

IndicationStatusPhase
DBCOND0064161 (Malignant Neoplasm of Female Breast)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03910712Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCTreatment
NCT04088110Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast CancerTreatment